美國癌症醫學會黑色素瘤臨床試驗：先免疫治療還是先手術？Pre-Surgery Immunotherapy vs. Post-Surgery Adjuvant Therapy
998 بار بازدید -
3 هفته پیش
-
大家好，我是腫瘤科吳教恩醫師。今天我要分享今年美國癌症醫學會的一項重要臨床試驗，這是一個針對第三期皮膚黑色素瘤的第三期臨床試驗。研究比較了先進行手術再做輔助性治療，與先進行引導式免疫治療再手術的效果。結果顯示，先進行免疫治療的效果更好。我將在影片中詳細探討這個題目，並分享我的見解。Hello everyone, I am Dr.
大家好，我是腫瘤科吳教恩醫師。今天我要分享今年美國癌症醫學會的一項重要臨床試驗，這是一個針對第三期皮膚黑色素瘤的第三期臨床試驗。研究比較了先進行手術再做輔助性治療，與先進行引導式免疫治療再手術的效果。結果顯示，先進行免疫治療的效果更好。我將在影片中詳細探討這個題目，並分享我的見解。
Hello everyone, I am Dr. Chiao-En Wu from the Department of Oncology. Today, I will share an important clinical trial from the American Society of Clinical Oncology (ASCO) this year. This phase III trial focused on stage III melanoma, comparing the outcomes of surgery followed by adjuvant therapy versus neoadjuvant immunotherapy before surgery. The results confirmed that pre-surgery immunotherapy yields better outcomes. I will discuss this topic in detail and share my insights in the video.
Hello everyone, I am Dr. Chiao-En Wu from the Department of Oncology. Today, I will share an important clinical trial from the American Society of Clinical Oncology (ASCO) this year. This phase III trial focused on stage III melanoma, comparing the outcomes of surgery followed by adjuvant therapy versus neoadjuvant immunotherapy before surgery. The results confirmed that pre-surgery immunotherapy yields better outcomes. I will discuss this topic in detail and share my insights in the video.
3 هفته پیش
در تاریخ 1403/04/16 منتشر شده
است.
998
بـار بازدید شده